胡志远 Zhiyuan Hu

中国科学院大学纳米学院教授，博士生导师，中科院特聘核心岗位研究员。复旦大学遗传学本科，美国约翰霍普金斯医学院生物化学博士。在美国系统生物学研究所（ISB），系统生物学奠基人李·胡德（Leroy Hood）教授实验室进行博士后研究，后聘为研究科学家，曾任美国FDA体外诊断医疗器械审评专家。主持了多项科技部、基金委、中科院、市科委项目。已在《Nature Communications》、《Advanced Materials》、《PNAS》、《J Clin. Invest.》等国际学术期刊上发表论文100余篇，申请发明专利30余项。任中国抗癌协会CTC技术专家委员会组长，中国CTC产业联盟理事长，福建医科大学、武汉工程大学的兼职博导，Phenomics杂志编委。

Professor at the School of Nanoscience and Technology, University of Chinese Academy of Sciences, doctoral supervisor, and CAS specially-appointed core position researcher. He received his bachelor’s degree in genetics from Fudan University and Ph.D. in biochemistry from Johns Hopkins University School of Medicine. He conducted postdoctoral research at the Institute for Systems Biology (ISB) in the laboratory of Professor Leroy Hood, founder of systems biology, and was later hired as a research scientist. He has served as an expert reviewer for in vitro diagnostic medical devices at the US FDA. He has led multiple projects from the Ministry of Science and Technology, NSFC, CAS, and municipal science and technology commissions. He has published over 100 papers in international academic journals such as Nature Communications, Advanced Materials, PNAS, and J Clin. Invest., and applied for over 30 invention patents. He serves as the head of the CTC Technology Expert Committee of the Chinese Anti-Cancer Association, president of the China CTC Industry Alliance, adjunct doctoral supervisor at Fujian Medical University and Wuhan Institute of Technology, and editorial board member of Phenomics journal.